Decibel Therapeutics Ownership 2024 | Who Owns Decibel Therapeutics Now?
Institutional Ownership
0.16%
Insider Ownership
13.36%
Retail Ownership
86.49%
Institutional Holders
1.00
Decibel Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ATLAS CAPITAL ADVISORS LLC | 0.16% | 0.01% | 40,000 | 15,000 | 60.00% | 36,400 | Sep 30, 2023 |
| WELLS FARGO & COMPANY/MN | - | - | - | -94 | -100.00% | - | Sep 30, 2023 |
| NORTHERN TRUST CORP | - | - | - | -19,091 | -100.00% | - | Sep 30, 2023 |
| BARCLAYS PLC | - | - | - | -10,855 | -100.00% | - | Sep 30, 2023 |
| DIMENSIONAL FUND ADVISORS LP | - | - | - | -34,607 | -100.00% | - | Sep 30, 2023 |
| BAILARD, INC. | - | - | - | -10,600 | -100.00% | - | Sep 30, 2023 |
| MORGAN STANLEY | - | - | - | -6,600 | -100.00% | - | Sep 30, 2023 |
| ROYAL BANK OF CANADA | - | - | - | -722 | -100.00% | - | Sep 30, 2023 |
| BESSEMER GROUP INC | - | - | - | -494,071 | -100.00% | - | Sep 30, 2023 |
| ORBIMED ADVISORS LLC | - | - | - | -4,945,192 | -100.00% | - | Sep 30, 2023 |
| FEDERATED HERMES, INC. | - | - | - | -20,000 | -100.00% | - | Sep 30, 2023 |
| HARVARD MANAGEMENT CO INC | - | - | - | -326,029 | -100.00% | - | Sep 30, 2023 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -115,567 | -100.00% | - | Sep 30, 2023 |
| BLACKROCK INC. | - | - | - | -1,811,483 | -100.00% | - | Sep 30, 2023 |
| BANK OF NEW YORK MELLON CORP | - | - | - | -40,489 | -100.00% | - | Sep 30, 2023 |
| NEUBERGER BERMAN GROUP LLC | - | - | - | -58,800 | -100.00% | - | Sep 30, 2023 |
| BRONTE CAPITAL MANAGEMENT PTY LTD. | - | - | - | -154,878 | -100.00% | - | Sep 30, 2023 |
| ACUITAS INVESTMENTS, LLC | - | - | - | -41,960 | -100.00% | - | Sep 30, 2023 |
| TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -2,867 | -100.00% | - | Sep 30, 2023 |
| NEWTYN MANAGEMENT, LLC | - | - | - | -200,000 | -100.00% | - | Sep 30, 2023 |
Decibel Therapeutics's largest institutional shareholder is ATLAS CAPITAL ADVISORS LLC, holding 0.16% of the company's total share outstanding, currently valued at $36.40K. The top 10 institutional shareholders own together 0.16% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ATLAS CAPITAL ADVISORS LLC | 0.16% | 0.01% | 40,000 | 15,000 | 60.00% | 36,400 | Sep 30, 2023 |
| WELLS FARGO & COMPANY/MN | - | - | - | -94 | -100.00% | - | Sep 30, 2023 |
| NORTHERN TRUST CORP | - | - | - | -19,091 | -100.00% | - | Sep 30, 2023 |
| BARCLAYS PLC | - | - | - | -10,855 | -100.00% | - | Sep 30, 2023 |
| DIMENSIONAL FUND ADVISORS LP | - | - | - | -34,607 | -100.00% | - | Sep 30, 2023 |
| BAILARD, INC. | - | - | - | -10,600 | -100.00% | - | Sep 30, 2023 |
| MORGAN STANLEY | - | - | - | -6,600 | -100.00% | - | Sep 30, 2023 |
| ROYAL BANK OF CANADA | - | - | - | -722 | -100.00% | - | Sep 30, 2023 |
| BESSEMER GROUP INC | - | - | - | -494,071 | -100.00% | - | Sep 30, 2023 |
| ORBIMED ADVISORS LLC | - | - | - | -4,945,192 | -100.00% | - | Sep 30, 2023 |
| FEDERATED HERMES, INC. | - | - | - | -20,000 | -100.00% | - | Sep 30, 2023 |
| HARVARD MANAGEMENT CO INC | - | - | - | -326,029 | -100.00% | - | Sep 30, 2023 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -115,567 | -100.00% | - | Sep 30, 2023 |
| BLACKROCK INC. | - | - | - | -1,811,483 | -100.00% | - | Sep 30, 2023 |
| BANK OF NEW YORK MELLON CORP | - | - | - | -40,489 | -100.00% | - | Sep 30, 2023 |
| NEUBERGER BERMAN GROUP LLC | - | - | - | -58,800 | -100.00% | - | Sep 30, 2023 |
| BRONTE CAPITAL MANAGEMENT PTY LTD. | - | - | - | -154,878 | -100.00% | - | Sep 30, 2023 |
| ACUITAS INVESTMENTS, LLC | - | - | - | -41,960 | -100.00% | - | Sep 30, 2023 |
| TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -2,867 | -100.00% | - | Sep 30, 2023 |
| NEWTYN MANAGEMENT, LLC | - | - | - | -200,000 | -100.00% | - | Sep 30, 2023 |
The largest Decibel Therapeutics shareholder by % of total assets is ATLAS CAPITAL ADVISORS LLC. The company owns 40.00K shares of Decibel Therapeutics (DBTX), representing 0.01% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ATLAS CAPITAL ADVISORS LLC | 0.16% | 0.01% | 40,000 | 15,000 | 60.00% | 36,400 | Sep 30, 2023 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -10 | -100.00% | - | Sep 30, 2023 |
| WELLS FARGO & COMPANY/MN | - | - | - | -94 | -100.00% | - | Sep 30, 2023 |
| ROYAL BANK OF CANADA | - | - | - | -722 | -100.00% | - | Sep 30, 2023 |
| UBS GROUP AG | - | - | - | -1,735 | -100.00% | - | Sep 30, 2023 |
| TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -2,867 | -100.00% | - | Sep 30, 2023 |
| MORGAN STANLEY | - | - | - | -6,600 | -100.00% | - | Sep 30, 2023 |
| FLAGSHIP HARBOR ADVISORS, LLC | - | - | - | -10,113 | -100.00% | - | Sep 30, 2023 |
| BAILARD, INC. | - | - | - | -10,600 | -100.00% | - | Sep 30, 2023 |
| BARCLAYS PLC | - | - | - | -10,855 | -100.00% | - | Sep 30, 2023 |
| BAIRD FINANCIAL GROUP, INC. | - | - | - | -14,900 | -100.00% | - | Sep 30, 2023 |
| NORTHERN TRUST CORP | - | - | - | -19,091 | -100.00% | - | Sep 30, 2023 |
| FEDERATED HERMES, INC. | - | - | - | -20,000 | -100.00% | - | Sep 30, 2023 |
| DIMENSIONAL FUND ADVISORS LP | - | - | - | -34,607 | -100.00% | - | Sep 30, 2023 |
| BANK OF NEW YORK MELLON CORP | - | - | - | -40,489 | -100.00% | - | Sep 30, 2023 |
| ACUITAS INVESTMENTS, LLC | - | - | - | -41,960 | -100.00% | - | Sep 30, 2023 |
| NEUBERGER BERMAN GROUP LLC | - | - | - | -58,800 | -100.00% | - | Sep 30, 2023 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -115,567 | -100.00% | - | Sep 30, 2023 |
| POINT72 ASSET MANAGEMENT, L.P. | - | - | - | -132,000 | -100.00% | - | Sep 30, 2023 |
| BRONTE CAPITAL MANAGEMENT PTY LTD. | - | - | - | -154,878 | -100.00% | - | Sep 30, 2023 |
As of Sep 30 2023, Decibel Therapeutics's largest institutional buyer is ATLAS CAPITAL ADVISORS LLC. The company purchased 15.00K stocks of DBTX, valued at $36.40K.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | - | - | - | -4,945,192 | -100.00% | - | Sep 30, 2023 |
| TRV GP III, LLC | - | - | - | -3,139,685 | -100.00% | - | Sep 30, 2023 |
| BLACKROCK INC. | - | - | - | -1,811,483 | -100.00% | - | Sep 30, 2023 |
| ALPHABET INC. | - | - | - | -1,636,258 | -100.00% | - | Sep 30, 2023 |
| BESSEMER GROUP INC | - | - | - | -494,071 | -100.00% | - | Sep 30, 2023 |
| HARVARD MANAGEMENT CO INC | - | - | - | -326,029 | -100.00% | - | Sep 30, 2023 |
| NEWTYN MANAGEMENT, LLC | - | - | - | -200,000 | -100.00% | - | Sep 30, 2023 |
| BRONTE CAPITAL MANAGEMENT PTY LTD. | - | - | - | -154,878 | -100.00% | - | Sep 30, 2023 |
| POINT72 ASSET MANAGEMENT, L.P. | - | - | - | -132,000 | -100.00% | - | Sep 30, 2023 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -115,567 | -100.00% | - | Sep 30, 2023 |
| NEUBERGER BERMAN GROUP LLC | - | - | - | -58,800 | -100.00% | - | Sep 30, 2023 |
| ACUITAS INVESTMENTS, LLC | - | - | - | -41,960 | -100.00% | - | Sep 30, 2023 |
| BANK OF NEW YORK MELLON CORP | - | - | - | -40,489 | -100.00% | - | Sep 30, 2023 |
| DIMENSIONAL FUND ADVISORS LP | - | - | - | -34,607 | -100.00% | - | Sep 30, 2023 |
| FEDERATED HERMES, INC. | - | - | - | -20,000 | -100.00% | - | Sep 30, 2023 |
| NORTHERN TRUST CORP | - | - | - | -19,091 | -100.00% | - | Sep 30, 2023 |
| BAIRD FINANCIAL GROUP, INC. | - | - | - | -14,900 | -100.00% | - | Sep 30, 2023 |
| BARCLAYS PLC | - | - | - | -10,855 | -100.00% | - | Sep 30, 2023 |
| BAILARD, INC. | - | - | - | -10,600 | -100.00% | - | Sep 30, 2023 |
| FLAGSHIP HARBOR ADVISORS, LLC | - | - | - | -10,113 | -100.00% | - | Sep 30, 2023 |
As of Sep 30 2023, Decibel Therapeutics's biggest institutional seller is ORBIMED ADVISORS LLC. The company sold -4.95M shares of DBTX, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | - | - | - | -4,945,192 | -100.00% | - | Sep 30, 2023 |
| TRV GP III, LLC | - | - | - | -3,139,685 | -100.00% | - | Sep 30, 2023 |
| BLACKROCK INC. | - | - | - | -1,811,483 | -100.00% | - | Sep 30, 2023 |
| ALPHABET INC. | - | - | - | -1,636,258 | -100.00% | - | Sep 30, 2023 |
| BESSEMER GROUP INC | - | - | - | -494,071 | -100.00% | - | Sep 30, 2023 |
| HARVARD MANAGEMENT CO INC | - | - | - | -326,029 | -100.00% | - | Sep 30, 2023 |
| NEWTYN MANAGEMENT, LLC | - | - | - | -200,000 | -100.00% | - | Sep 30, 2023 |
| BRONTE CAPITAL MANAGEMENT PTY LTD. | - | - | - | -154,878 | -100.00% | - | Sep 30, 2023 |
| POINT72 ASSET MANAGEMENT, L.P. | - | - | - | -132,000 | -100.00% | - | Sep 30, 2023 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -115,567 | -100.00% | - | Sep 30, 2023 |
| NEUBERGER BERMAN GROUP LLC | - | - | - | -58,800 | -100.00% | - | Sep 30, 2023 |
| ACUITAS INVESTMENTS, LLC | - | - | - | -41,960 | -100.00% | - | Sep 30, 2023 |
| BANK OF NEW YORK MELLON CORP | - | - | - | -40,489 | -100.00% | - | Sep 30, 2023 |
| DIMENSIONAL FUND ADVISORS LP | - | - | - | -34,607 | -100.00% | - | Sep 30, 2023 |
| FEDERATED HERMES, INC. | - | - | - | -20,000 | -100.00% | - | Sep 30, 2023 |
| NORTHERN TRUST CORP | - | - | - | -19,091 | -100.00% | - | Sep 30, 2023 |
| BAIRD FINANCIAL GROUP, INC. | - | - | - | -14,900 | -100.00% | - | Sep 30, 2023 |
| BARCLAYS PLC | - | - | - | -10,855 | -100.00% | - | Sep 30, 2023 |
| BAILARD, INC. | - | - | - | -10,600 | -100.00% | - | Sep 30, 2023 |
| FLAGSHIP HARBOR ADVISORS, LLC | - | - | - | -10,113 | -100.00% | - | Sep 30, 2023 |
| MORGAN STANLEY | - | - | - | -6,600 | -100.00% | - | Sep 30, 2023 |
| TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -2,867 | -100.00% | - | Sep 30, 2023 |
| UBS GROUP AG | - | - | - | -1,735 | -100.00% | - | Sep 30, 2023 |
| ROYAL BANK OF CANADA | - | - | - | -722 | -100.00% | - | Sep 30, 2023 |
| WELLS FARGO & COMPANY/MN | - | - | - | -94 | -100.00% | - | Sep 30, 2023 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -10 | -100.00% | - | Sep 30, 2023 |
Decibel Therapeutics's largest sold out institutional shareholder by shares sold is ORBIMED ADVISORS LLC, sold -4.95M shares, valued at -, as of undefined.
Decibel Therapeutics Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| BlackRock Health Sciences Trust II | 0.30% | 793,527 | - | - | Mar 31, 2024 |
| BlackRock Health Sciences Trust | 0.19% | 46,884 | - | - | Mar 31, 2024 |
| BRIDGEWAY FUNDS INC | 0.05% | 114,400 | - | - | Mar 28, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.03% | 15,840 | - | - | Mar 31, 2024 |
| FEDERATED HERMES INSURANCE SERIES | 0.00% | 10,000 | - | - | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.00% | 1,170 | - | - | Mar 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.00% | 9,460 | - | - | Mar 31, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 612,893 | - | - | Mar 31, 2024 |
| JPMORGAN INSURANCE TRUST | 0.00% | 15,517 | -784 | -4.81% | Mar 31, 2023 |
| Federated Hermes Equity Funds | 0.00% | 20,000 | - | - | Jan 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 119,197 | - | - | Feb 29, 2024 |
| BlackRock ETF Trust | 0.00% | 353 | - | - | Jan 31, 2024 |
| Voya INVESTORS TRUST | 0.00% | 20,056 | - | - | Mar 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 10,874 | - | - | Mar 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 580 | - | - | Mar 31, 2024 |
| BLACKROCK FUNDS | 0.00% | 897,801 | - | - | Mar 28, 2024 |
| THRIVENT SERIES FUND INC | 0.00% | 13,043 | - | - | Mar 28, 2024 |
| VICTORY PORTFOLIOS | 0.00% | 3,545 | - | - | Mar 31, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.00% | 4,700 | - | - | Feb 29, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 2,292 | - | - | Feb 29, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 3,107 | - | - | Feb 29, 2024 |
| NORTHERN FUNDS | 0.00% | 3,261 | - | - | Mar 28, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 1,300 | - | - | Mar 31, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 1,927 | - | - | Jan 31, 2024 |
| ProFunds | 0.00% | 155 | - | - | Mar 31, 2024 |
| VALIC Co I | 0.00% | 3,384 | - | - | Feb 29, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 21,806 | - | - | Feb 29, 2024 |
| FIDELITY SALEM STREET TRUST | 0.00% | 40,472 | - | - | Mar 31, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 1,209 | - | - | Mar 31, 2024 |
| MUTUAL FUND SERIES TRUST | 0.00% | 37,500 | - | - | Mar 31, 2024 |
| PROSHARES TRUST | 0.00% | 2,100 | - | - | Feb 29, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 16,042 | - | - | Mar 31, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 1,313 | - | - | Jan 31, 2024 |
| PACIFIC SELECT FUND | 0.00% | 20,803 | - | - | Mar 31, 2024 |
| SEASONS SERIES TRUST | 0.00% | 126 | - | - | Mar 31, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 5,175 | - | - | Jan 31, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 433 | - | - | Feb 29, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 4,477 | - | - | Mar 31, 2024 |
| TIAA-CREF FUNDS | 0.00% | 11,549 | - | - | Mar 31, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 69 | - | - | Feb 29, 2024 |
| EQ ADVISORS TRUST | 0.00% | 2,867 | - | - | Mar 31, 2024 |
| iSHARES TRUST | 0.00% | 34,624 | - | - | Mar 31, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 771 | - | - | Mar 31, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 462 | - | - | Jan 31, 2024 |
| JPMorgan Trust I | 0.00% | 1,670 | - | - | Jan 31, 2024 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 898 | - | - | Dec 31, 2023 |
| Bridge Builder Trust | 0.00% | 2,142 | - | - | Mar 31, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 543 | - | - | Mar 31, 2024 |
| PRINCIPAL FUNDS, INC. | 0.00% | 1,246 | - | - | Feb 29, 2024 |
| BlackRock Variable Series Funds, Inc. | 0.00% | 780 | - | - | Mar 31, 2024 |
Decibel Therapeutics's largest mutual fund holder by % of total assets is "BlackRock Health Sciences Trust II", owning 793.53K shares, compromising 0.30% of its total assets.
Decibel Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 31 Dec, 23 | 1 | - |
| 30 Sep, 23 | 1 | -97.30% |
| 30 Jun, 23 | 37 | 2.78% |
| 31 Mar, 23 | 36 | -12.20% |
| 31 Dec, 22 | 41 | -2.38% |
| 30 Sep, 22 | 42 | -10.64% |
| 30 Jun, 22 | 47 | 17.50% |
| 31 Mar, 22 | 40 | -2.44% |
| 31 Dec, 21 | 41 | 20.59% |
| 30 Sep, 21 | 34 | -22.73% |
| 30 Jun, 21 | 44 | -18.52% |
| 31 Mar, 21 | 54 | - |
As of 31 Dec 23, 1 institutions are holding Decibel Therapeutics's shares, representing an increase of 0.00% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 31 Dec, 23 | 40,000 | - |
| 30 Sep, 23 | 40,000 | -99.74% |
| 30 Jun, 23 | 15,383,385 | -0.45% |
| 31 Mar, 23 | 15,453,071 | -12.55% |
| 31 Dec, 22 | 17,670,645 | -1.51% |
| 30 Sep, 22 | 17,941,148 | 0.40% |
| 30 Jun, 22 | 17,868,796 | 1.01% |
| 31 Mar, 22 | 17,690,566 | 0.75% |
| 31 Dec, 21 | 17,558,900 | -7.21% |
| 30 Sep, 21 | 18,923,408 | -3.44% |
| 30 Jun, 21 | 19,597,054 | -1.77% |
| 31 Mar, 21 | 19,950,485 | - |
Decibel Therapeutics (DBTX) has 40.00K shares outstanding as of 31 Dec 23, up 0.00% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 31 Dec, 23 | 0.16% | 625.39% |
| 30 Sep, 23 | 0.16% | 0.00% |
| 30 Jun, 23 | 61.49% | 1.61% |
| 31 Mar, 23 | 61.84% | 1.23% |
| 31 Dec, 22 | 70.80% | 1.37% |
| 30 Sep, 22 | 71.87% | 1.40% |
| 30 Jun, 22 | 71.59% | 1.42% |
| 31 Mar, 22 | 70.89% | 1.43% |
| 31 Dec, 21 | 70.38% | 1.22% |
| 30 Sep, 21 | 76.07% | 1.22% |
| 30 Jun, 21 | 78.81% | 1.06% |
| 31 Mar, 21 | 86.27% | - |
As of 31 Dec 23, Decibel Therapeutics is held by 0.16% institutional shareholders, representing a 625.39% growth compared to 30 Sep 23.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 31 Dec, 23 | - | -100.00% |
| 30 Sep, 23 | 1 | -88.89% |
| 30 Jun, 23 | 9 | -30.77% |
| 31 Mar, 23 | 13 | 8.33% |
| 31 Dec, 22 | 12 | - |
| 30 Sep, 22 | 12 | -36.84% |
| 30 Jun, 22 | 19 | 35.71% |
| 31 Mar, 22 | 14 | 16.67% |
| 31 Dec, 21 | 12 | 9.09% |
| 30 Sep, 21 | 11 | -38.89% |
| 30 Jun, 21 | 18 | -66.67% |
| 31 Mar, 21 | 54 | - |
- institutional shareholders have increased their position in DBTX stock as of 31 Dec 23 compared to 1 in the previous quarter (a -100.00% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 31 Dec, 23 | - | - |
| 30 Sep, 23 | - | -100.00% |
| 30 Jun, 23 | 9 | -10.00% |
| 31 Mar, 23 | 10 | -28.57% |
| 31 Dec, 22 | 14 | 16.67% |
| 30 Sep, 22 | 12 | - |
| 30 Jun, 22 | 12 | 50.00% |
| 31 Mar, 22 | 8 | -33.33% |
| 31 Dec, 21 | 12 | 20.00% |
| 30 Sep, 21 | 10 | -33.33% |
| 30 Jun, 21 | 15 | - |
| 31 Mar, 21 | - | - |
- institutional shareholders have reduced their position in DBTX stock as of 31 Dec 23 compared to - in the previous quarter (a 0.00% increase).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 31 Dec, 23 | 1 | - | 40,000 | - | 0.16% | 625.39% | - | -100.00% | - | - |
| 30 Sep, 23 | 1 | -97.30% | 40,000 | -99.74% | 0.16% | 0.00% | 1 | -88.89% | - | -100.00% |
| 30 Jun, 23 | 37 | 2.78% | 15,383,385 | -0.45% | 61.49% | 1.61% | 9 | -30.77% | 9 | -10.00% |
| 31 Mar, 23 | 36 | -12.20% | 15,453,071 | -12.55% | 61.84% | 1.23% | 13 | 8.33% | 10 | -28.57% |
| 31 Dec, 22 | 41 | -2.38% | 17,670,645 | -1.51% | 70.80% | 1.37% | 12 | - | 14 | 16.67% |
| 30 Sep, 22 | 42 | -10.64% | 17,941,148 | 0.40% | 71.87% | 1.40% | 12 | -36.84% | 12 | - |
| 30 Jun, 22 | 47 | 17.50% | 17,868,796 | 1.01% | 71.59% | 1.42% | 19 | 35.71% | 12 | 50.00% |
| 31 Mar, 22 | 40 | -2.44% | 17,690,566 | 0.75% | 70.89% | 1.43% | 14 | 16.67% | 8 | -33.33% |
| 31 Dec, 21 | 41 | 20.59% | 17,558,900 | -7.21% | 70.38% | 1.22% | 12 | 9.09% | 12 | 20.00% |
| 30 Sep, 21 | 34 | -22.73% | 18,923,408 | -3.44% | 76.07% | 1.22% | 11 | -38.89% | 10 | -33.33% |
| 30 Jun, 21 | 44 | -18.52% | 19,597,054 | -1.77% | 78.81% | 1.06% | 18 | -66.67% | 15 | - |
| 31 Mar, 21 | 54 | - | 19,950,485 | - | 86.27% | - | 54 | - | - | - |
Decibel Therapeutics Insider Shareholders Trades
Open Market Insider Trades
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Decibel Therapeutics's stock was made by Trask Anna on Sep 25 2023, selling 106,864 shares at $3.50 per share (valued at $374.02K).
Decibel Therapeutics Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2023 | - | 29 | - |
| Q2 2023 | 8 | - | - |
| Q1 2023 | 8 | - | - |
| Q4 2022 | 1 | - | - |
| Q2 2022 | 5 | - | - |
| Q1 2022 | 4 | 2 | 200.00% |
| Q4 2021 | 2 | 5 | 40.00% |
| Q3 2021 | 2 | - | - |
| Q2 2021 | 1 | - | - |
| Q1 2021 | 33 | 37 | 89.19% |
0 total buy trades, and 29 total sell trades (buy/sell ratio of 0.00%) were made by Decibel Therapeutics's insiders, as of Q3 2023.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2023 | - | - | - |
| Q2 2023 | - | - | - |
| Q1 2023 | - | - | - |
| Q4 2022 | - | - | - |
| Q2 2022 | - | - | - |
| Q1 2022 | - | 2 | - |
| Q4 2021 | - | 5 | - |
| Q3 2021 | 1 | - | - |
| Q2 2021 | - | - | - |
| Q1 2021 | 7 | - | - |
As of Q3 2023, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Decibel Therapeutics's stocks.
Decibel Therapeutics Peer Ownership
| Ticker | Company |
|---|---|
| IKNA | Ikena Oncology, Inc. |
| EWTX | Edgewise Therapeutics, Inc. |
| AVTE | Aerovate Therapeutics, Inc. |
| ACRV | Acrivon Therapeutics, Inc. Common Stock |
| ANTX | AN2 Therapeutics, Inc. |
| HCWB | HCW Biologics Inc. |
| CCCC | C4 Therapeutics, Inc. |
| RZLT | Rezolute, Inc. |
| HOWL | Werewolf Therapeutics, Inc. |
| ANEB | Anebulo Pharmaceuticals, Inc. |
| ADAG | Adagene Inc. |
| MOLN | Molecular Partners AG |
| CELC | Celcuity Inc. |
| ELYM | Eliem Therapeutics, Inc. |
DBTX Ownership FAQ
Who Owns Decibel Therapeutics?
Decibel Therapeutics is owned by institutional shareholders (0.16%), insiders (13.36%), and public (86.49%). The largest institutional shareholder of Decibel Therapeutics is ATLAS CAPITAL ADVISORS LLC (0.16% of total shares) and the top mutual fund owner is BlackRock Health Sciences Trust II (0.30% of total shares).
Who are the major institutional shareholders of Decibel Therapeutics?
Decibel Therapeutics's major institutional shareholders are ATLAS CAPITAL ADVISORS LLC, WELLS FARGO & COMPANY/MN, NORTHERN TRUST CORP, BARCLAYS PLC, and DIMENSIONAL FUND ADVISORS LP. The top five shareholders own together 0.16% of the company's share outstanding.
How many Decibel Therapeutics shareholders are there?
As of Dec 2023, there are 1 institutional shareholders of Decibel Therapeutics.
What percentage of Decibel Therapeutics is owned by ATLAS CAPITAL ADVISORS LLC?
ATLAS CAPITAL ADVISORS LLC owns 40K shares of Decibel Therapeutics, representing 0.16% of the company's total shares outstanding, valued at $36.4K (as of Sep 2023).
What percentage of Decibel Therapeutics is owned by WELLS FARGO & COMPANY/MN?
As of Sep 2023, WELLS FARGO & COMPANY/MN holds 0 shares of Decibel Therapeutics (DBTX), compromising 0% of the company, valued at $0.
What percentage of Decibel Therapeutics is owned by NORTHERN TRUST CORP?
NORTHERN TRUST CORP is the third largest holder of Decibel Therapeutics. The company owns 0 of the company's shares outstanding (worth $0).